Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/24/1996 | CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
10/24/1996 | CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
10/24/1996 | CA2216751A1 Conotoxin peptides |
10/24/1996 | CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions |
10/23/1996 | EP0738779A2 Direct cloning of PCR amplified nucleic acids |
10/23/1996 | EP0738736A1 Monoclonal antibodies to gp130, and their uses |
10/23/1996 | EP0738394A1 Ubiquitin conjugating enzymes |
10/23/1996 | EP0738332A1 Indicator cell line for detecting rna viruses and method therefor |
10/23/1996 | EP0738328A1 Composition containing nucleic acids, preparation and uses |
10/23/1996 | EP0738327A1 Host-vector system for use in gene therapy |
10/23/1996 | EP0738326A1 tfdA GENE SELECTABLE MARKERS IN PLANTS AND THE USE THEREOF |
10/23/1996 | EP0738325A1 Receptor specific bacterial adhesins and their use |
10/23/1996 | EP0738324A1 Synergistic antifungal protein and compositions containing same |
10/23/1996 | EP0738323A1 Thrombopoietin |
10/23/1996 | EP0738322A1 T cell antigen receptor v region proteins and methods of preparation thereof |
10/23/1996 | EP0738321A1 Association of kinesin with sensitivity to chemotherapeutic drugs |
10/23/1996 | EP0738320A1 Synthetic antimicrobial peptides |
10/23/1996 | EP0738319A1 Purification of retroviral vectors |
10/23/1996 | EP0738281A1 Peptides and methods against psoriasis |
10/23/1996 | EP0738279A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
10/23/1996 | EP0738278A1 Expression of surface layer proteins |
10/23/1996 | EP0738277A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences |
10/23/1996 | EP0738272A1 Method and separation substrate for analysing mononucleotides and oligonucleotides |
10/23/1996 | EP0673437A4 Hepadnavirus polymerase having rna-dependent dna priming and reverse transcriptase activities and methods of measuring these activities. |
10/23/1996 | EP0646124A4 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor. |
10/23/1996 | EP0640143A4 Senescent cell derived inhibitors of dna synthesis. |
10/23/1996 | EP0431072B1 Recombinant fowlpox virus |
10/23/1996 | EP0422125B1 Platelet blocking peptides |
10/23/1996 | EP0379559B1 Method and reagents for detecting nucleic acid sequences |
10/23/1996 | EP0276262B1 Merozoite surface antigen of plasmodium falciparum |
10/23/1996 | CN1134175A Viral vector with bovine viral diarrhea virus (BVDV) antigens |
10/23/1996 | CN1134174A Modified plant viruses as vectors of heterologous peptides |
10/23/1996 | CN1134173A Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
10/23/1996 | CN1134172A Protocadherin proteins and their uses |
10/23/1996 | CN1134171A DNA coding for phosphoenolpyravate carboxkinase, recombinant vector contg. same, and transgenic plant |
10/23/1996 | CN1134156A Synthesizing and screening molecular diversity |
10/23/1996 | CN1134113A Method for inducing antigen-specific T cell tolerance |
10/23/1996 | CN1134111A Method of using insulin-like growth factor binding proteins |
10/23/1996 | CN1134109A Chemically-defined non-polymeric valency plateform molecules and conjugates thereof |
10/23/1996 | CN1133888A Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
10/23/1996 | CN1133887A Regulatory gene for expression of nitrile hydratase gene |
10/23/1996 | CN1133886A Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them |
10/22/1996 | US5567862 Synthetic insecticidal crystal protein gene |
10/22/1996 | US5567811 Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides |
10/22/1996 | US5567807 Using an anionic exchange resin |
10/22/1996 | US5567687 Useful in photodynamic therapy and light-induced cleavage of a polymer of deoxyribonucleic acid |
10/22/1996 | US5567617 Apparatus for heating a fluid-carrying compartment of reaction cuvette |
10/22/1996 | US5567611 Multifunctional M-CSF proteins and genes encoding therefor |
10/22/1996 | US5567607 Transferring dna into embryos using electrical discharges |
10/22/1996 | US5567604 Anti-viral guanosine-rich oligonucleotides |
10/22/1996 | US5567603 HIV-3 retrovirus and its use |
10/22/1996 | US5567602 Recombinant production of chymase |
10/22/1996 | US5567601 Subtilisin mutants lacking a primary calcium binding site |
10/22/1996 | US5567600 Synthetic insecticidal crystal protein gene |
10/22/1996 | US5567599 Method for producing transformed chrysanthemum plants |
10/22/1996 | US5567588 Forming nucleic acid-target complexes; partitioning increased affinity nucleic acids; amplification |
10/22/1996 | US5567584 Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
10/22/1996 | US5567582 Dna sequences |
10/22/1996 | CA1338664C Recombinant hosts |
10/22/1996 | CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them |
10/17/1996 | WO1996032641A1 Novel protein from dirofilaria immitis and method for immunodiagnosis of heartworm in mammals |
10/17/1996 | WO1996032503A1 Reverse two-hybrid systems |
10/17/1996 | WO1996032501A1 Process for reducing the formation of artefacts during transcription of rebonucleic acids to deoxynucleic acids |
10/17/1996 | WO1996032496A2 Covalently linked oligonucleotide minor groove binder conjugates |
10/17/1996 | WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same |
10/17/1996 | WO1996032489A1 Glucose-inducible recombinant viral vector |
10/17/1996 | WO1996032488A1 S-adenosyl-l-homocystein hydrolyse promoter |
10/17/1996 | WO1996032487A1 Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface |
10/17/1996 | WO1996032486A1 Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface |
10/17/1996 | WO1996032485A1 Phospholipase c homolog |
10/17/1996 | WO1996032484A2 ACETYL-CoA CARBOXYLASE COMPOSITIONS AND METHODS OF USE |
10/17/1996 | WO1996032483A1 Immune-evading proteins |
10/17/1996 | WO1996032482A1 Bacteriocins |
10/17/1996 | WO1996032481A1 New chemokine expressed in eosinophils |
10/17/1996 | WO1996032480A2 METHODS AND COMPOSITIONS FOR DETERMINING HER-2/neu EXPRESSION |
10/17/1996 | WO1996032479A1 Hookworm vaccine |
10/17/1996 | WO1996032478A1 Altered polypeptides with increased half-life |
10/17/1996 | WO1996032477A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
10/17/1996 | WO1996032474A1 Cooperative oligonucleotides |
10/17/1996 | WO1996032473A1 Dumbbell sense oligonucleotide for inhibiting herpes simplex virus (hsv) |
10/17/1996 | WO1996032468A2 Bioprocess for production of dipeptide based compounds |
10/17/1996 | WO1996032417A1 Antibodies against heart muscle actin |
10/17/1996 | WO1996032413A1 Process for the purification of glycoproteins like erythropoietin |
10/17/1996 | WO1996032407A1 Igf-i purification process |
10/17/1996 | WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein |
10/17/1996 | WO1996032087A2 Transgenic fish in the treatment of diabetes |
10/17/1996 | WO1996032007A1 Transgenic tomato plants containing a fusarium resitance gene |
10/17/1996 | WO1996027006A3 Human vegf-specific antisense oligonucleotides |
10/17/1996 | WO1996025491A3 Inhibition of proliferation of vascular smooth muscle cell |
10/17/1996 | WO1996023066A3 Prostaglandin receptor, dp |
10/17/1996 | WO1996022375A3 Procedures and materials for conferring disease resistance in plants |
10/17/1996 | WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
10/17/1996 | WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
10/17/1996 | WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms |
10/17/1996 | WO1996016173A3 Modified proteinase inhibitors |
10/17/1996 | WO1996016084A3 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
10/17/1996 | DE19514056A1 Protein expression system regulatable by acetate, pH or oxygen |
10/17/1996 | CA2393381A1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
10/17/1996 | CA2218139A1 Acetyl-coa carboxylase compositions and methods of use |
10/17/1996 | CA2217977A1 Immune-evading proteins |